• Home
  • Search Results

Search Results

Young Adult (18-34)
Cancer
403 studies match your search

A STUDY OF SELINEXOR AND VENETOCLAX WITH CHEMOTHERAPY IN PATIENTS WITH REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA

The purpose of this study is to test the safety of the two study drugs, venetoclax and selinexor, and to find the highest dose of venetoclax and selinexor that can be given safely when it is combined with chemotherapy drugs (cytarabine or cytarabine and fludarabine). This study tests different doses of venetoclax and selinexor to see which dose is safer in children with leukemia.

Age & Gender
  • 2 years ~ 30 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Leukemia)
  • Child and Teen Health
Visit Location
100% Remote (online, phone, text)

Detecting the Chimeric Antigen Receptor T-cells Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Patients with Multiple Myeloma

Research with blood and cells (generally called specimens) can help researchers understand how the human body works. Research can also answer other questions by using specimens. Researchers may develop new tests to find diseases, or new ways to treat diseases. In the future, research may help to develop new products, such as drugs. You are being asked for permission to use your biospecimens and medical records for this study. Using your biospecimens, researchers may be able to detect CAR-T cells in your body after you receive the CAR-T treatment. The purpose of this study is to validate the detection method of CAR-T cells in the blood to advance CAR-T therapy development.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
Visit Location
100% Remote (online, phone, text)

Spanish Colorectal Cancer + Clinical Trial Educational Study

The purpose of this study is to create an educational video on colorectal cancer, screening and prevention, and clinical trials in Spanish in order to demonstrate a correlation between increased education and increased willingness to participate in clinical trials in the Latinx populations through local churches.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
  • Minority Health
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Using Patient-Reported Data to Address Racial Disparities in Cancer Treatment Delay

Purpose: To develop, assess, and refine a brief electronic patient-reported outcome (ePRO) tool that can be completed weekly by patients with newly diagnosed breast and colorectal cancer to self-report progress from diagnosis to treatment initiation.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast, Colorectal)
Visit Location
100% Remote (online, phone, text)

Rural Endometrial Cancer Patients Providers and Healthcare Administrators

The purpose of this project is to identify and target barriers faced by rural endometrial cancer patients in order to develop a patient navigation intervention. Rural residents with endometrial cancer, the most prevalent gynecologic cancer in the US, have higher odds of mortality than urban endometrial cancer patients. As the number of new endometrial cancer cases is expected to increase 50% by 2030, this urban-rural disparity is expected to continue widening.

Age & Gender
  • 18 years ~ 99 years
  • Female, Focus on recruitment of transgender men
Study Interest
  • Cancer (Uterine (endometrial))
  • Women's Health
Visit Location
100% Remote (online, phone, text)

Rural Endometrial Cancer Patients

The purpose of this project is to identify and target barriers faced by rural endometrial cancer patients in order to develop a patient navigation intervention. Rural residents with endometrial cancer, the the most prevalent gynecologic cancer in the US, have higher odds of mortality than urban endometrial cancer patients. As the number of new endometrial cancer cases is expected to increase 50% by 2030, this urban-rural disparity is expected to continue widening.

Age & Gender
  • 18 years ~ 99 years
  • Female, Focus on recruitment of transgender men
Study Interest
  • Cancer (Uterine (endometrial))
  • Women's Health
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.

Age & Gender
  • 0 days ~ 22 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Leukemia)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

cGVHD study

Collecting data on chronic GVHD instances

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
  • Immune System/Infections
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

The purpose of this study is to evaluate the efficacy of sodium thiosulfate (STS) infusion administered during cisplatin-containing chemotherapy cycles in reducing hearing loss in children with newly-diagnosed average-risk medulloblastoma.

Age & Gender
  • 4 years ~ 21 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
  • Cancer (Brain and Other Nervous System, Pediatric Cancers)
  • Child and Teen Health
  • Ear, Nose, and Throat
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Nasal Swab to Evaluate Lung Cancer Risk

The DNA that we can test from a nasal swab, can help us determine a patient's lung cancer risk. For patients with new lung nodules found on CT scans, we are offering this nasal swab test and collecting data on how physicians use test results to help assess risk and determine treatment strategies.

Age & Gender
  • 29 years ~ 85 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
  • Lungs and Breathing
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research